Role of CT and MRCP in Evaluation of Biliary Tract Obstruction


Obstructive jaundice which is caused by bile duct obstruction can be clinically and biochemically indistinguishable from cholestatic jaundice caused by hepatocellular disease. The management of both these conditions being radically different, the principle task of the radiologist is to differentiate between hepatocellular and obstructive jaundice, using available imaging modality and help in further management. With the availability of non-invasive modality like computed tomography and magnetic resonance imaging (MRI), it is possible to diagnose obstructive jaundice early and accurately without any patient discomfort. The purpose of this article is to describe the protocol for evaluation of obstructive jaundice with use of MDCT and magnetic resonance cholangio pancreatography sequence of MRI and to describe the imaging features of the most common causes of obstructive jaundice like biliary calculi, bile duct strictures, choledochal cyst, gall bladder carcinoma, cholangiocarcinoma, primary sclerosing cholangitis, and pancreatic head carcinoma.


Obstructive jaundice is a type of jaundice in which there is blockage of flow of bile from the liver to the intestine resulting in redirection of excess bile and its by products like bilirubin into the blood. It can lead to complications like ascending cholangitis, hepatorenal syndrome, and malabsorbtion and hence requires urgent surgical intervention. The role of radiologist therefore is important in early diagnosis and in accurately delineating the level and the cause of obstruction, thus helping in staging as well as preoperative assessment of tumor respectability.

For long, Endoscopic Retrograde Cholangio Pancreatography (ERCP) was the standard established procedure for evaluation of patients with obstructive jaundice. However, being an invasive procedure, it has an inherent complication rate of 3–9 % and mortality rate of 0.2–0.5 % [1]. Due to significant advances in cross-sectional imaging, in particular the advent of magnetic resonance cholangio pancreatography (MRCP), ERCP currently has an almost exclusively therapeutic role.

Endoscopic Ultrasound (EUS), an adjunct procedure to ERCP, can be used to detect small distal biliary ductal calculi, for local staging of periampullary neoplasm and for guided fine-needle aspiration.

Ultrasonography (USG) can be used as initial imaging modality to diagnose the biliary obstruction but artifacts due to bowel gas, gall bladder and bile duct calculi, breathing artifacts and obesity brings it down in the list of imaging modality of choice in obstructive jaundice.

With recent advances in MDCT technology enabling faster acquisition in a single breath hold and upgraded software techniques for image reconstruction, MDCT is now more sensitive for determining the preliminary level and cause of obstruction. Due to sub-second acquisition and multiphasic approach, newer studies have further refined the role of MDCT in terms of specific diagnosis and staging of the pathology. Thus, single breath hold, multiphasic, sub centimeter iso-voxel scanning with post processing through volume acquisition, maximum intensity projections (MIPs), and multiplanar reformations (MPR) all help to increase the diagnostic accuracy, which is immensely helpful in

  1. a)

    Differentiating benign from malignant stricture.

  2. b)

    Staging complex biliary malignancies in terms of involvement of biliary confluence, invasion, and encasement of the adjacent major arterial and venous channel rendering it inoperable, as well as regional lymphadenopathy and hepatic metastasis.

Hence, Multiphasic MDCT of the abdomen with pancreatic and venous phase through the hepatic-biliary-pancreatic region is now the accepted worldwide protocol for pancreatico-biliary malignancies.

Magnetic resonance (MR) imaging besides being non-invasive has the advantages of allowing detailed evaluation of the pancreatico-biliary tract with a large field of view (FOV), excellent patient tolerance, and three-dimensional (3D) data sets that can be cholangio-pancreatico graphically displayed. Two unique properties of bile that are exploited to produce MRCP images are its relatively high water content & stasis of bile, in comparison with the blood flowing through adjacent vessels in the portal tract [2•], producing projection images like ERCP. Hence, MRCP has virtually replaced ERCP as the primary investigative modality in all cases of obstructive jaundice not requiring early endoscopic intervention.

Method of Evaluation


In newer MRI machines, with state of the art imaging capability, MRCP can be performed either without the use of contrast agent or with the usage of contrast agent showing biliary excretion.

Non-contrast MRCP

Non-contrast MRCP technique is based on heavily T2 weighted sequence which can be performed in two-dimensional (2D) or 3D modes [3•]. It shows increased signal from bile and pancreatic duct (PD) fluid and suppresses signal from background tissues such as solid organs and moving blood [4, 5]. The imaging obstacles of long acquisition times and respiratory motion artifacts have largely been overcome with technical innovations such as short-breath-hold T2-weighted acquisitions, parallel imaging, and sophisticated respiratory triggering mechanisms. The parameters we used for non-contrast MRCP sequence in our institute are as follows (Table 1).

Table 1 Imaging protocol for MRCP on 3T philips machine

Contrast MRCP

Contrast-enhanced MRCP is based on the principle of selective excretion of liver specific, gadolinium-, and magnesium-based MR contrast media by the liver into the biliary system, in 10–60 min [6]. These excreted contrast media cause T1 shortening of the bile, resulting in hyperintensity on T1w sequences. The liver-specific contrast agents are gadobenate dimeglumine (Gd-BOPTA), gadoxetic acid disodium (gadoxetate disodium, or Gd-EOB-DTPA), and mangafodipir trisodium (Mn-DPDP). In our institute, the most commonly used sequence for contrast MRCP is e-THRIVE (fat-saturated T1 weighted fast gradient sequence), which can be acquired in a single breath hold of 20–22 s, reducing the breathing-related artifact. The main indication of contrast MRCP is in evaluation of biliary leak, which can occur either due to iatrogenic trauma or at the site of anastomosis in case of liver transplantation. Contrast MRCP gives advantage over non-contrast MRCP in determining the exact site of leak and in giving information about the communication of this leak with surrounding collection, if any. However, being gadolinium-based technique, it suffers from the inherent complications related to gadolinium like risk of nephrogenic systemic fibrosis in patients of renal failure and allergic reactions [7]. The other disadvantage is longer scan duration to obtain significant concentration of gadolinium in the biliary system.

Advantage of 3 T Over 1.5 T

The signal to noise ratio (SNR) at 3.0 T is twice that at 1.5 T, producing higher-resolution image data sets with reduced acquisition times. The visualization of arborization of intrahepatic ducts, bile duct variations, delineation of the PD particularly its side branches, and relation of the pancreatic parenchyma to the ductal system is better obtained at 3.0 T than at 1.5 T. Also signal from fluid in the gastrointestinal tract is more effectively suppressed at 3.0 T. Use of parallel imaging reduces acquisition time and hence reduces breathing-related artifacts. All this encourages the use of this modality for specific diagnostic applications like in diagnosis of primary sclerosing cholangitis [8].


In our institute, plain abdominal CT is obtained at 120 kV, 200 mAs to determine baseline HU value and to visualize any biliary calculi containing calcium. To determine post contrast enhancement, 90 ml of non-ionic iodinated contrast (350 mg % v/w) is injected intravenously at a flow rate of 3 ml/sec with the aid of pressure injector (Mallinckrodt). Arterial and venous phase are taken at an interval of 18–22 & 60–65 s, respectively, from the time of contrast injection. Delayed phase is taken after 10–15 min. Delayed phase is particularly important in cases of cholangiocarcinoma which show increased contrast enhancement as compared to normal surrounding parenchyma. 3D reconstruction with thin planar (1 mm) and MPR is performed in coronal and sagittal planes for better depiction of intraluminal and wall lesions of biliary tract.

Normal Anatomy of Pancreato-Biliary System in MRCP (Fig. 1)

Bile plays an important role in intestinal absorption. It is secreted by the liver and is transported into the duodenum through the biliary system. There is significant variation seen in the biliary tree, with normal biliary anatomy seen only in 50–60 % of the population. Hence, the basic knowledge of its normal anatomy and its variant is important to differentiate from the pathology. Biliary system consists of intrahepatic and extrahepatic components. The intrahepatic component is formed by various biliary radicles draining the respective hepatic segments. Biliary radicles draining segments V, VIII form right anterior bile duct which is oriented vertically, and biliary radicles draining segment VI, VII form right posterior bile duct which is oriented horizontally. These right anterior and posterior bile ducts combine to form right hepatic duct (RHD). Biliary radicles draining segments II, III, and IV form left hepatic duct (LHD). The LHD and RHD combine together to form the common hepatic duct (CHD). Segment I is drained by separate biliary radicles draining in the angle of RHD & LHD. The extra-hepatic biliary system consists of CHD & common bile duct (CBD). CHD and cystic duct combine together to form the CBD. Both CBD and common hepatic artery are seen anterior to the portal vein, with CBD on the right and hepatic artery on the left. CBD normally measures 5 mm up to 50 years of age and shows an increment of 1 mm per decade. Pancreas is drained by PD which is embryologically derived from the fusion of the ventral duct of Wirsung (major PD) and the dorsal duct of Santorini (minor PD). Non-fusion of these ducts forms most common variant called pancreatic divisum seen in up to 14 % of population. The PD and CBD join together in the medial wall of D2 segment of duodenum forming a common channel. The terminal segments of CBD, PD, and this common channel are surrounded by a smooth muscle, called sphincter of Oddi.

Fig. 1

a Schematic diagram and b MIP 3D MRCP sequence showing normal anatomy of pancreatico-biliary tract. RHD right hepatic duct, LHD left hepatic duct, CHD common hepatic duct, CBD common bile duct, PD pancreatic duct, D2 2nd segment of duodenum, CD cystic duct

Biliary Calculi

Cholelithiasis is a common cause (Table 2) of acute abdominal pain due to calculus cholecystitis and is one of the main indications for cholecystectomy. Cholelithiasis is twice more common in females than males. 80 % gall bladder calculi are composed of more than 50 % cholesterol and are seen mainly in patients of obesity, diabetes, and undergoing rapid weight loss. The remaining 20 % of calculi are bile pigment calculi mainly seen in patients of hemolytic anemia. Small calculus can cause biliary obstruction by its easy passage into the bile duct, or a recent passage of calculi can lead to benign distal CBD stricture (Fig. 2). Biliary obstruction can also be caused by a calculus that has impacted in the region of gall bladder neck and causes extrinsic compression of bile duct with resultant obstructive jaundice, this being known as Mirizzi’s syndrome.

Table 2 Common causes of obstructive jaundice in both adult and paediactric age group
Fig. 2

MRCP 3D image showing a smooth short segment stricture (arrow) in the distal CBD due to recent passage of calculus. Gall Bladder is studded with multiple calculi manifesting as multiple filling defects (arrowhead)

Magnetic resonance cholangio pancreatography is comparable to ERCP for the detection of choledocholithiasis and is superior to CT and USG, as it can detect calculi as small as 2 mm in size, which are seen as filling defects surrounded by T2 hyperintense bile (Fig. 3). For further characterization of stones, routine T1 and T2 weighted sequences are needed, on which pigmented stones appear hyperintense on T1 as compared to cholesterol stones which appear hypointense. Air bubbles are a common diagnostic pitfall but usually can be differentiated from stones by their smooth, rounded appearance and their tendency to cluster together and rise to the nondependent surface. At CT, biliary calculi can have variable appearance, ranging from highly calcified lamellated radio dense calculi to low-density calculi due to cholesterol content (Fig. 4). Air bubble can be easily differentiated from calculi on CT depending on its HU value. Local irritation caused by the stone or associated cholangitis may lead to findings of wall thickening, mucosal enhancement, and periductal fat stranding. However, in the presence of mural enhancement possibility of malignancy should be considered [9].

Fig. 3

a Schematic diagram, b single shot thick slab MRCP shows multiple well defined rounded filling defects (arrowhead) in a dilated CBD surrounded by T2 hyperintense bile s/o choledocholithiasis

Fig. 4

Plain CT scan in axial (a) and reconstructed oblique coronal images (b) showing multiple gall bladder calculi (arrowhead) and impacted distal CBD calculus (long arrow) causing proximal dilatation of the bile duct (short arrow)

Benign Biliary Stricture

The major cause of benign biliary stricture is surgical trauma, other causes being gall stone, duodenal ulcer, and chronic pancreatitis. Incidence of post-operative stricture has increased in the recent period due to increase in number of laparoscopic procedures. Post-operative stricture can present month to years after the operation and mainly occurs due to ischemic or direct traumatic injury to the duct. Post inflammatory stricture like in case of choledocholithiasis, due to chronic irritation and inflammation, is seen manly in CBD and is short in length. Stricture due to chronic pancreatitis is seen in the region of pancreatic head and is usually 3–5 cms in length.

The main concern while reporting benign stricture is to differentiate it from malignant stricture. While ERCP has been the gold standard for a long time for evaluation of strictures, a recent study by Park et al. in 2004 found MRCP to be more sensitive than ERCP. Sensitivity, specificity, and accuracy for the differentiation of malignant from benign causes of biliary stricture at MRCP were 81, 70, and 76 % respectively, and at ERCP were 74, 70, and 72 % [9].

Certain features can differentiate benign from malignant stricture. Features like wall thickness less than 1.5 mm, length of stricture less than 9 mm, and upstream bile duct dilatation of <17 mm are more of suggestive of benign stricture (Figs. 5, 6). MRCP finding of a dilated bile duct showing smooth and sudden tapering is diagnostic of post-operative biliary stricture. In addition, MRCP can accurately depict the anatomical level and length of stricture which is helpful in its operative management [10]. CT scan can show complications associated with stricture like cholangitis and associated abscess. Bismuth H [11] (Table 3) classified post-operative strictures into five types.

Fig. 5

a Schematic diagram and b MIP 3D MRCP showing short length benign stricture involving CHD (arrow head)

Fig. 6

Schematic diagram showing differentiation between benign and malignant stricture

Table 3 Bismuth classification of post-operative strictures

Choledochal Cyst

Choledochal cyst is a congenital anomaly involving biliary tree characterized by cystic dilatation of bile ducts manifesting usually after the age of 10 years. Clinically it is difficult to diagnose as most of the patients are asymptomatic. A classical triad of jaundice, pain, and right upper quadrant palpable lump, however, is seen in 30–60 % of patients diagnosed before the age of 10 and in 10 % of the cases diagnosed in adulthood [12].

Many theories exist regarding the patho-physiology of choledochal cyst, but the most accepted one is of anomalous pancreatico-biliary junction (APBJ). ABPJ is found in 10–58 % cases of choledochal cyst (Fig. 7). Two features are considered responsible for the development of choledochal cyst; a length of more than 15 mm of the common channel formed after the union of PD and CBD outside the wall of duodenum and the angle of union between PD and CBD; both these features allowing reflux of pancreatic juice in the bile ducts causing their ectatic dilatation. Based on these two features, Komi et al. [13] classified APBJ into three types. In Type I, there is a right angle between the ducts, which is sub-classified into type IA (without dilatation) and type IB (with dilatation) of the common channel. In Type II, there is acute angle between the ducts which is also sub-classified into type IIA (without dilatation) and type IIB (with dilatation) of the common channel. Type III unions are defined by more complex patterns of accessory PDs.

Fig. 7

a 3D MRCP b thick slab single shot MRCP showing focal dilatation of extra-hepatic bile duct (Type I B Choledochal cyst) (thick arrow) with anomalous pancreato-biliary junction (minor duct opening into CBD) (thin arrow)

Depending on the location and number of choledochal cysts, Todani et al. [14] (Table 4) classified choledochal cyst into five types as follows.

Table 4 Todani classification of choledochal cyst

Type I choledochal cyst is the most common type. The complication associated with choledochalcyst is recurrent cholecystitis, choledocholithiasis, pancreatitis, and malignant transformation to cholangiocarcinoma [15]. The role of imaging in choledochal cyst is to localize it, determine its relationship to adjacent structures, to evaluate the complications related to it, and look for any associated biliary tree abnormalities. USG can be used as initial screening modality however it may be difficult to evaluate the bile duct due to bowel gas.

On CT, it is seen as large cyst with fluid density in the region of porta communicating with bile duct. MRCP is an extremely useful tool for detection and classification of choledochal cysts (Fig. 8). It is particularly important in cases of patient with choledochal cysts associated with bile duct stricture, in which ERCP is suboptimal due to non-opacification bile duct distal to stricture [16].

Fig. 8

a Schematic diagram of type 1C choledochal cyst. b Thick slab MRCP image of type IC choledochal cyst showing fusiform dilatation of extrahepatic bile duct (arrow) with normal intrahepatic bile ducts associated with complication as cholelithiasis with in dilated duct (arrow head)

Gall Bladder Carcinoma

Gall bladder cancer most often occurs in elderly women and is usually associated with gallstones (90 % of cases). Other risk factors include a chronic typhoid carrier state, choledochal cyst, gall bladder polyp, anomalous APBJ, and porcelain gallbladder. About 20 % of patients with porcelain gallbladder develop gallbladder cancer. Gall bladder carcinomas are characterized by local invasion, extensive regional lymph node metastasis, vascular encasement, and distant metastases. In general, it is the most aggressive of the biliary cancers with the shortest median survival duration and requires early surgical intervention. Hence early diagnosis is crucial for patient management.

Obstructive jaundice can occur either due to invasion of gall bladder mass in the region of porta (Figs. 9, 10) or due to metastatic portal lymphadenopathy compressing the bile duct. Morphologically, gallbladder carcinoma can present as a mass completely occupying or replacing the gallbladder lumen, focal, or diffuse asymmetric gallbladder wall thickening or as an intraluminal polypoidal lesion [17]. Mass forming type is the most common, causing obstructive jaundice due to hilar extension [18].

Fig. 9

MDCT in axial, coronal, and sagittal planes depicts a heterogeneously enhancing mass lesion replacing gall bladder in the region of gall bladder fossa (arrow) with localized invasion in the adjacent liver and porta causing intra-hepatic biliary dilatation (arrowhead). Metallic biliary stent noted in situ (thin arrow)

Fig. 10

Image a: schematic diagram of mass forming type of gall bladder carcinoma. Image b: T2 coronal image showing mass forming type of gall bladder carcinoma with local spread in hepatic hilum and involving CHD and part of CBD (arrow heads). Normal CBD is seen in the region of pancreatic head (arrow). Image c: MIP 3D MRCP sequence showing non visualization of gall bladder, CHD and part of CBD with intrahepatic bile duct dilatation. A thin linear T2 hyperintense structure in the region of CHD extending in the duodenal loop s/o biliary stent (arrow head). Normal CBD is seen in the region of pancreatic head

On contrast-enhanced CT, gall bladder carcinoma is seen as an enhancing mass in the region of gall bladder fossa, asymmetric wall thickening or as an enhancing large (>1 cm) intraluminal polypoidal mass [18]. MDCT with multi-planar reconstruction helps in evaluation of local spread (in liver, hepatic flexure of colon, duodenum) vascular involvement, metastatic lymphadenopathy, and metastasis (liver, peritoneal) which help in staging and determining the resectability of tumor.

Magnetic resonance cholangio pancreatography helps in evaluation of hilar extension of mass forming type of gall bladder carcinoma, which is seen as intrahepatic bile duct dilatation on MRCP sequences. Intraluminal polypoidal type is seen as a lesion arising from the wall of gall bladder casing peripheral filling defect. However, gall bladder calculus can also produce similar filling defect, hence additional T1, T2 W and contrast images are required for confirmation of diagnosis.


Cholangiocarcinoma is a tumor arising from the bile duct epithelium and it can arise from anywhere along the bile duct.

Anatomically cholangiocarcinoma can be classified as [19, 20•]

  1. 1)

    Intrahepatic (peripheral) arises from beyond second-order bile ducts.

  2. 2)

    Perihilar (Klatskin tumors)-arises at the bifurcation of the hepatic ducts involving CHD and biliary ducts up to second-order bifurcation.

  3. 3)

    Extrahepatic-arising from CBD.

Morphologically, according to the Japanese Liver Cancer Group, tumor growth can be described as.

  1. 1)

    Mass-forming (exophytic)

  2. 2)

    Periductal (infiltrating) (Fig. 11)

    Fig. 11

    a and b contrast-enhanced coronal images of CT scan showing long segment enhancing wall thickening involving CHD and CBD (arrow head) with secondary upstream dilatation of intrahepatic bile ducts (arrow)

  3. 3)

    Intraductal (polypoidal) (Fig. 12)

    Fig. 12

    Contrast-enhanced Axial, coronal, and sagittal planes in portal phase showing an enhancing endoluminal polypoidal mass (arrows) in the mid common bile duct, causing proximal biliary dilatation

  4. 4)

    Mixed (mass forming and periductal) pattern.

Out of all the types of cholangiocarcinoma, perihilar is the most common type, presenting as jaundice and shows infiltrating pattern. Bismuth and Corlette classified perihilarcholangiocarcinoma (Klatskin tumors) depending on extent of ductal involvement (Table 5) (Fig. 13).

Table 5 Bismuth and Corlette classification of peri-hilar cholangiocarcinoma (Klatskin tumor)
Fig. 13

Schematic diagram and MRCP images of types of Klatskin’s tumors. Figure a, b-Type I cholangiocarcinoma, showing involvement of CHD with patent confluence. Figure c, d-Type II cholangiocarcinoma, showing involvement of CHD and first-order branches of RHD and LHD. Figure e, f-Type IIIA cholangiocarcinoma, showing involvement of CHD and of RHD up to its second-order branch. Figure g, h-Type IV cholangiocarcinoma, showing involvement of both right and left hepatic ducts up to their second-order branches

Apart from localization of level of obstruction and cause of obstruction, contrast-enhanced CT scan helps in determining the morphological type of cholangiocarcinoma, local spread, vascular involvement and determining stage and resectability of tumor. In cases of cholangiocarcinoma, delayed scan at 10–15 min is particularly important as it is shows delayed enhancement.

Magnetic resonance cholangio pancreatography plays vital role in evaluation of biliary tumors and has replaced ERCP and percutaneous transhepatic cholangiography (PTC) in many centers. The reported sensitivity and specificity of MRCP compared to ERCP for the detection of bile duct malignancy are 81 and 100 % compared to 93 and 94 %, respectively [18]. The main advantage of MRCP over ERCP is that it can evaluate the extent of involvement and the dilated biliary tract beyond the level of obstruction which cannot be evaluated in ERCP due inadequate opacification of biliary tract distal to the obstruction [21, 22]. The main drawback of MRCP over ERCP is that it is only diagnostic.

The main feature of malignant biliary stricture on MRCP is long segment, irregular narrowing of biliary tract with upstream asymmetric dilation. The information which is required in the management of hilar carcinoma is the level of obstruction, extent of involvement, whether the involvement is up to primary or second-order branches and associated choledocholithiasis [23]; all can be obtained from MRCP images [22]. MRCP provides only endoluminal images from fluid, hence sometimes it could be inadequate to differentiate between benign and malignant stricture. In such cases, conventional T2, T1 W and contrast images give added advantage by visualization of malignant mass, metastasis, and metastatic lymphadenopathy.

Primary Sclerosing Cholangitis

Primary sclerosing cholangitis is an uncommon idiopathic inflammatory condition characterized by fibrosis of the biliary tree. As the disease progresses, it leads tocholestasis and in 49 % of symptomatic patients finally to biliary cirrhosis and liverdamage. The risk of developing cholangiocarcinoma is 10–15 % among primary sclerosing cholangitis patients. Young to middle age males around fourth decade are the most frequently affected. It is strongly associated with inflammatory bowel disease, most commonly ulcerative colitis.

The finding of wall thickening with dilatation of bile duct can be seen in CT however only these findings are not sufficient for diagnosis of PSC. In normal subjects on MRCP, only the central ducts containing adequate bile can be seen. Peripheral small biliary radicles are not seen as there is insufficient pressure to distend them. Multiple stricturous involvement of central bile ducts in PSC prevents contrast opacification of peripheral bile ducts, producing prune tree appearance on ERCP. However, because of generation of back pressure in these peripheral small bile ducts, they can be appreciated on MRCP giving an added advantage over ERCP. A study done by Fulcher et al. [24], found sensitivity of 88 % for MRCP as compared to ERCP in diagnosis of PSC.

The characteristic finding of PSC is multiple alternating short segment strictures and slightly dilated intervening bile duct segments leading to bead on string appearance (Fig. 14). In addition to this classical finding, formation of mural nodules, thickening of the duct wall, diverticula and webs, although not pathognomonic for primary sclerosing cholangitis, can be observed. Up to 27 % of patients with primary sclerosing cholangitis have diverticula. Being non-invasive modality, it is particularly important for screening of such patients avoiding the complication related to invasive ERCP. Additional conventional T1 and T2 W sequences also help in early diagnosis of the rare complication of cholangiocarcinoma related to PSC.

Fig. 14

a Schematic diagram and b single shot MRCP showing multiple strictures involving intra- and extra-hepatic biliary tract (arrow heads) in case of primary sclerosing cholangitis

Pancreatic Head Tumors

Cancer of pancreas is currently the ninth most common malignancy but represent the fourth most common cause of cancer-related death in the United States. In clinical practice, pancreatic tumor is synonymous with adenocarcinoma which accounts for 90–95 % of cases. Up to 75 % of cases, the tumor is located within the pancreatic head which can cause biliary obstruction. Pancreatic tumors are well known to present late leading to delayed diagnosis and poor prognosis. The role of imaging in pancreatic carcinoma is

  1. 1)

    Confirming the diagnosis.

  2. 2)

    Localizing the lesion.

  3. 3)

    Staging the tumor.

  4. 4)

    Determining the respectability.

  5. 5)

    Advising the surgeon preoperatively of relevant anatomical vascular variants.

Although multi-detector CT still plays an important role in local invasion and extent of bile duct obstruction, MRI has an advantage of tissue characterization with respect to few of the tumors like lympho-proliferative disorders (Figs. 15, 16) showing diffusion restriction. The characteristic imaging finding on MRCP is of obstruction leading to dilatation of PD, common bile duct, or both. Dilatation of both ducts leads to double-duct sign (Fig. 17). Other finding suggestive of malignant cause is irregular narrowing of pancreatic and bile duct in the region of pancreatic head.

Fig. 15

a and b this patient is a 32-year-old lady with 6-week history of abdominal pain, intermittent vomiting, and jaundice. A contrast-enhanced multidetector CT scan showing lobulated minimally enhancing mass in the head of the pancreas, encasing the a long segment of the common bile duct (arrow) with the resultant proximal biliary dilatation (arrowhead)

Fig. 16

a, b, and c T2 weighted fat-suppressed images in axial and coronal planes of the same patient in Fig. 16, showing intermediate signal intensity inhomogeneous soft tissue mass in the head of pancreas with encasement and narrowing of common bile duct (arrow) causing proximal duct dilatation. DWI images showing foci of diffusion restriction of the pancreatic mass (arrowhead) with renal deposits (small arrow) representing a lymphoproliferative disorder. A lobulated soft tissue bowel mass is seen in the pelvis showing intermediate to hyperintense signal intensity on T2 W fat-suppressed images (star)

Fig. 17

a Schematic diagram and b single shot MRCP showing dilated CBD and PD (double-duct sign) in their entire extent with abrupt cutoff in the region of pancreatic head due to peri-ampullary tumor (arrow head) associated with over distended gall bladder(black star)


In this newer era of imaging where multiple imaging modalities ranging from simple radiograph to most advanced MRI are available, it is the role of radiologist to guide the clinician in selecting the right imaging modality and to answer the questions which are important in patient management. Although ultrasound remains a screening modality for diagnosis of biliary obstruction, it is unable to answer the true extent and cause of obstructive jaundice requiring the use of another imaging modality like CECT and MRCP which scores over ultrasound in the diagnostic accuracy. MRCP can be considered as the new gold standard for the investigation of biliary obstruction and permits reservation of ERCP to patients with a high probability of therapeutic intervention.


Recently published papers of particular interest have been highlighted as: • Of importance

  1. 1.

    Rana SS, Bhasin DK, Sharma V, Rao C, Gupta R, Singh K. Role of endoscopic ultrasound in evaluation of unexplained common bile duct dilatation on magnetic resonance cholangiopancreatography. Ann Gastroenterol. 2013;26(1):66–70.

    PubMed  PubMed Central  Google Scholar 

  2. 2.

    • Patel HT, Shah AJ, Khandelwal SR, Patel HF, Patel MD. MR cholangiopancreatography at 3.0 T. Radiographics: a review publication of the Radiological Society of North America, Inc. 2009;29(6):1689–706. Describes and illustrates in detail 3.0T MRCP appearances of normal biliary tract anatomy, variants and benign and malignant pathologies.

  3. 3.

    • Yeh BM, Liu PS, Soto JA, Corvera CA, Hussain HK. MR imaging and CT of the biliary tract. Radiographics : a review publication of the Radiological Society of North America, Inc. 2009;29(6):1669–88. Gives good knowledge about the benefits and limitations of modern MR & CT cholangiographic technique and the use of biliary specific contrast media.

  4. 4.

    Romagnuolo J, Bardou M, Rahme E, Joseph L, Reinhold C, Barkun AN. Magnetic resonance cholangiopancreatography: a meta-analysis of test performance in suspected biliary disease. Ann Intern Med. 2003;139(7):547–57.

    PubMed  Article  Google Scholar 

  5. 5.

    Wallner BK, Schumacher KA, Weidenmaier W, Friedrich JM. Dilated biliary tract: evaluation with MR cholangiography with a T2-weighted contrast-enhanced fast sequence. Radiology. 1991;181(3):805–8.

    PubMed  Article  CAS  Google Scholar 

  6. 6.

    Yeh BM, Breiman RS, Taouli B, Qayyum A, Roberts JP, Coakley FV. Biliary tract depiction in living potential liver donors: comparison of conventional MR, mangafodipir trisodium-enhanced excretory MR, and multi-detector row CT cholangiography–initial experience. Radiology. 2004;230(3):645–51.

    PubMed  Article  Google Scholar 

  7. 7.

    Marckmann P, Skov L, Rossen K, Dupont A, Damholt MB, Heaf JG, et al. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol. 2006;17(9):2359–62.

    PubMed  Article  Google Scholar 

  8. 8.

    O’Regan DP, Fitzgerald J, Allsop J, Gibson D, Larkman DJ, Cokkinos D, et al. A comparison of MR cholangiopancreatography at 1.5 and 3.0 tesla. Br J radiol. 2005;78(934):894–8.

    PubMed  Article  Google Scholar 

  9. 9.

    Park MS, Kim TK, Kim KW, Park SW, Lee JK, Kim JS, et al. Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP. Radiology. 2004;233(1):234–40.

    PubMed  Article  Google Scholar 

  10. 10.

    Govil H, Reddy V, Kluskens L, Treaba D, Massarani-Wafai R, Selvaggi S, et al. Brush cytology of the biliary tract: retrospective study of 278 cases with histopathologic correlation. Diagn Cytopathol. 2002;26(5):273–7.

    PubMed  Article  Google Scholar 

  11. 11.

    Bismuth H, Majno PE. Biliary strictures: classification based on the principles of surgical treatment. World J Surg. 2001;25(10):1241–4.

    PubMed  Article  CAS  Google Scholar 

  12. 12.

    Marx FW Jr, Gray RK, Duncan AM, Bakhtiar L. Angiodysplasia as a source of intestinal bleeding. Am J Surg. 1977;134(1):125–30.

    PubMed  Article  Google Scholar 

  13. 13.

    Komi N, Takehara H, Kunitomo K, Miyoshi Y, Yagi T. Does the type of anomalous arrangement of pancreaticobiliary ducts influence the surgery and prognosis of choledochal cyst? J Pediatr Surg. 1992;27(6):728–31.

    PubMed  Article  CAS  Google Scholar 

  14. 14.

    Todani T, Watanabe Y, Narusue M, Tabuchi K, Okajima K. Congenital bile duct cysts: classification, operative procedures, and review of thirty-seven cases including cancer arising from choledochal cyst. Am J Surg. 1977;134(2):263–9.

    PubMed  Article  CAS  Google Scholar 

  15. 15.

    Wiseman K, Buczkowski AK, Chung SW, Francoeur J, Schaeffer D, Scudamore CH. Epidemiology, presentation, diagnosis, and outcomes of choledochal cysts in adults in an urban environment. Am J Surg. 2005;189(5):527–31 discussion 31.

    PubMed  Article  Google Scholar 

  16. 16.

    Park DH, Kim MH, Lee SK, Lee SS, Choi JS, Lee YS, et al. Can MRCP replace the diagnostic role of ERCP for patients with choledochal cysts? Gastrointest Endosc. 2005;62(3):360–6.

    PubMed  Article  Google Scholar 

  17. 17.

    Levy AD, Murakata LA, Rohrmann CA Jr. Gallbladder carcinoma: radiologic-pathologic correlation. Radiographics. 2001;21(2):295–314 questionnaire, 549-55.

    PubMed  Article  CAS  Google Scholar 

  18. 18.

    Szklaruk J, Tamm E, Charnsangavej C. Preoperative imaging of biliary tract cancers. Surg Oncol Clin N Am. 2002;11(4):865–76.

    PubMed  Article  Google Scholar 

  19. 19.

    Sainani NI, Catalano OA, Holalkere NS, Zhu AX, Hahn PF, Sahani DV. Cholangiocarcinoma: current and novel imaging techniques. Radiographics. 2008;28(5):1263–87.

    PubMed  Article  Google Scholar 

  20. 20.

    • Chung YE, Kim MJ, Park YN, Choi JY, Pyo JY, Kim YC, et al. Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. Radiographics : a review publication of the Radiological Society of North America, Inc. 2009;29(3):683–700. Illustrates detail imaging appears of various type of cholangiocarcinoma on CT and MRI and recent advance in imaging of biliary tract.

  21. 21.

    Manfredi R, Masselli G, Maresca G, Brizi MG, Vecchioli A, Marano P. MR imaging and MRCP of hilar cholangiocarcinoma. Abdom Imaging. 2003;28(3):319–25.

    PubMed  Article  CAS  Google Scholar 

  22. 22.

    Pavone P, Laghi A, Passariello R. MR cholangiopancreatography in malignant biliary obstruction. Semin Ultrasound CT MR. 1999;20(5):317–23.

    PubMed  Article  CAS  Google Scholar 

  23. 23.

    Yeh TS, Jan YY, Tseng JH, Chiu CT, Chen TC, Hwang TL, et al. Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings. Am J gastroenterol. 2000;95(2):432–40.

    PubMed  Article  CAS  Google Scholar 

  24. 24.

    Fulcher AS, Turner MA. Orthotopic liver transplantation: evaluation with MR cholangiography. Radiology. 1999;211(3):715–22.

    PubMed  Article  CAS  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Anagha Joshi.

Additional information

This article is part of topical collection on Abdominal CT Imaging.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Joshi, A., Rajpal, K., Kakadiya, K. et al. Role of CT and MRCP in Evaluation of Biliary Tract Obstruction. Curr Radiol Rep 2, 72 (2014).

Download citation


  • CT
  • MRCP
  • Obstructive jaundice
  • Biliary stricture
  • Cholangiocarcinoma
  • Choledocholithiasis